InvestorsHub Logo
Followers 1
Posts 464
Boards Moderated 0
Alias Born 11/08/2011

Re: None

Friday, 03/14/2014 4:49:50 PM

Friday, March 14, 2014 4:49:50 PM

Post# of 12606
Really all that is needed is that break even at which point you can even take it from a measley $1M profit per year the EPS = .005 x 40 = where we are now (.2)

To, based on future / projected growth or when they wrap up the year / announce clinics underway, etc. etc. etc., a profit of $7-$10M in profit x a normal factor that they project out is $1.40 to $2 WITHOUT future projections of the additional revenue growth from additional locations and without alternate services/products...

The projected revenue of all of the above could easily cross $100M expected profit x 15 EPS (multiplier comes down since it is projected from $10M to $100M which is a factor of 10 itself and not atypical of biotech stocks) = $7.50 - $11 (that is realistic within 1-2 years of continued expansion and acceptance).

The stock is easily a $1 stock, but almost as easily $4. Some slight difficulty, but mostly just time and normal growth for a year or two and you will see $10 with no problems (or if the multipliers are outrageous cause of the bull market then that could just as easily be $20-$50).

I am really interested to see what management has planned for the future. They already have a venture capitalist on board and have since the days of Centrone Energy. Thus, I think they will very actively find additional revenue streams / services to provide.

Limitless potential for the next 3-5 years :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BICX News